Effect of dynamic atrioventricular and interventricular delay optimization for cardiac resynchronization therapy on cardiac function and neuroendocrine factors in patients with congestive heart failure
Authors:
Open Access
- 8 February 2021
- journal article
- letter
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 17 (2) , 551-556
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapyBMC Cardiovascular Disorders, 2019
- Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy in Older Adults With Heart FailureJournal of the American Geriatrics Society, 2019
- Cardiac resynchronization therapy: a comprehensive reviewMinerva Medica, 2019
- Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT)International Journal of Cardiology, 2019
- The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2019
- Eligibility for Cardiac Resynchronization Therapy in Patients Hospitalized with Heart FailureESC Heart Failure, 2018
- Long-term impact of intrathoracic impedance findings on survival and heart failure hospitalizations after cardiac resynchronization therapy in ICD Registry patientsEP Europace, 2017
- Heart rate and dyssynchrony in patients with cardiac resynchronization therapy: a pilot studyScandinavian Cardiovascular Journal, 2017
- Cardiac Resynchronization Therapy in Heart Failure Patients with Less Severe Left Ventricular DysfunctionEuropean Journal of Heart Failure, 2014
- 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesCirculation, 2012